verapamil has been researched along with Carotid Stenosis in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paclitaxel has been shown to inhibit vascular smooth muscle cell migration and proliferation contributing to neointimal formation." | 5.32 | Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. ( Cho, MC; Kim, DW; Kim, MS; Kim, YG; Kwon, JS; Lee, GS; Youn, TJ, 2004) |
| "Paclitaxel has been shown to inhibit vascular smooth muscle cell migration and proliferation contributing to neointimal formation." | 1.32 | Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. ( Cho, MC; Kim, DW; Kim, MS; Kim, YG; Kwon, JS; Lee, GS; Youn, TJ, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DW | 1 |
| Kwon, JS | 1 |
| Kim, YG | 1 |
| Kim, MS | 1 |
| Lee, GS | 1 |
| Youn, TJ | 1 |
| Cho, MC | 1 |
| Inoue, T | 1 |
| Shimizu, H | 1 |
| Okabe, H | 1 |
| Tominga, T | 1 |
| Winterkorn, JM | 1 |
| Kupersmith, MJ | 1 |
| Wirtschafter, JD | 1 |
| Forman, S | 1 |
3 other studies available for verapamil and Carotid Stenosis
| Article | Year |
|---|---|
Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model.
Topics: Administration, Oral; alpha-Tocopherol; Animals; ATP Binding Cassette Transporter, Subfamily B, Memb | 2004 |
Amaurosis fugax caused by retinal artery vasospasm. Case illustration.
Topics: Adult; Amaurosis Fugax; Aspirin; Calcium Channel Blockers; Carotid Artery, Internal; Carotid Stenosi | 2007 |
Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers.
Topics: Adult; Aged; Blindness; Carotid Stenosis; Embolism; Female; Humans; Male; Middle Aged; Nifedipine; R | 1993 |